---
title: "Adial Pharmaceuticals (ADIL.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ADIL.US/norm.md"
symbol: "ADIL.US"
name: "Adial Pharmaceuticals"
parent: "https://longbridge.com/zh-CN/quote/ADIL.US.md"
datetime: "2026-05-21T05:55:34.403Z"
locales:
  - [en](https://longbridge.com/en/quote/ADIL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADIL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADIL.US/norm.md)
---

# Adial Pharmaceuticals (ADIL.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -1.48 | -1.82 | -2.02 | -4.61 | -8.52 |
| ROE | -179.89% | -163.26% | -142.13% | -203.03% | -287.83% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -2.02M | -2.00M | -1.79M | -1.96M | -2.23M |
| 营业利润 | -2.00M | -1.89M | -1.76M | -1.88M | -2.27M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 5.23M | 6.67M | 5.66M | 6.80M | 3.45M |
| 权益乘数 | 1.41 | 1.26 | 1.26 | 1.22 | 1.62 |
| 每股净资产 | 2.46 | 4.75 | 4.72 | 6.49 | 8.00 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 4.58M | 5.88M | 4.61M | 5.91M | 2.37M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | - | - | - | - | - |
| 净债务 | -4.58M | -5.88M | -4.61M | -5.91M | -2.37M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -1.61M | -1.32M | -1.83M | -1.75M | -1.59M |
| 投资现金流 | - | 0.0000 | 0.0000 | 0.0000 | 150000.00 |
| 融资现金流 | 315284.00 | 2.60M | 524682.00 | 5.30M | 50648.00 |
| 自由现金流 | -1.06M | -660154.00 | -1.26M | -1.07M | -786740.00 |
| 现金流充裕率 | - | - | - | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |